pharmaphorum
JANUARY 9, 2022
US medical device company Abbott has said it plans to launch a new range of ‘biowearable’ health devices aimed at consumers, in a move that builds on its expertise in glucose monitoring. The company’s chief executive – Robert Ford – made the announcement at the massive CES tech trade show in Las Vegas, a venue usually dedicated to new TVs, gaming equipment, new smartphones and the like.
Outsourcing Pharma
JANUARY 12, 2022
The company plans to launch a Phase Ib/II study of its compound NVG-291 in collaboration with researchers at Northwestern Universityâs Shirley Ryan AbilityLab.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Fierce Healthcare
JANUARY 10, 2022
Investors poured record-breaking $29.1B into digital health startups. Will the momentum continue in 2022? hlandi. Mon, 01/10/2022 - 12:17.
Pharma Times
JANUARY 13, 2022
AstraZeneca (AZ) has reported preliminary data from a trial it conducted on its COVID-19 booster shot, Vaxzevria.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
pharmaphorum
JANUARY 14, 2022
Japanese pharma group Otsuka has led a $10 million first-round financing of GrayMatters Health, an Israeli company developing a digital health approach to the management of mental illness. Otsuka Medical Devices is also taking some rights to GrayMatters’ platform – called Prism – in Japan and some other Asian countries in connection with the financing, which was supported by Joy Ventures, J-Ventures, J-Impact, and existing backers Marius Nacht and Joyance Ventures.
Outsourcing Pharma
JANUARY 10, 2022
Joining with a noted research foundation, the group is aiming for earlier detection and treatment of the disease, which hits nearly 500K people annually.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Pharma Times
JANUARY 11, 2022
The partnership between Oxford University and SEEQC promises to accelerate the use of quantum computing within pharmaceutical research in order to reduce the development time required for drug production worldwide.
pharmaphorum
JANUARY 12, 2022
Roche has launched what it says is a first-of-its kind handheld glucose management device, backed up by a digital platform that aims to simplify the work of doctors and nurses as they deliver care to patients. The cobas pulse system is a point-of-care device that combines a glucose test strip reader with a touch screen that is used for displaying patient information and data, as well as analysing and sharing clinical results.
Outsourcing Pharma
JANUARY 13, 2022
With the amount of available data increasing and technology evolving, says a company leader, the job of data manager is more demanding than ever before.
Fierce Healthcare
JANUARY 14, 2022
HHS renews COVID-19 public health emergency order for another 90 days. rking. Fri, 01/14/2022 - 11:27.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Pharma Times
JANUARY 12, 2022
Under current guidelines, individuals that test positive for COVID-19 may be able to leave self-isolation after 7 days if certain conditions are met.
pharmaphorum
JANUARY 11, 2022
With evidence growing that the current crop of COVID-19 vaccines are less protective against infection with Omicron, both Pfizer and Moderna have announced plans to develop new versions of their mRNA-based shots that are tailored to the new variant. Pfizer has said that a COVID-19 jab specifically targeting Omicron, as well as other existing variants, will begin human trials later this month and could be available as early as March.
Outsourcing Pharma
JANUARY 14, 2022
The World Health Organization has recommended the drugs for COVID-19 patients, broadening the range of therapies to combat the virus behind the pandemic.
Fierce Healthcare
JANUARY 10, 2022
Insurers must cover at-home COVID-19 tests starting Jan. 15 under new CMS directive. rking. Mon, 01/10/2022 - 16:18.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Pharma Mirror
JANUARY 14, 2022
Amsterdam, CPhI Worldwide – the world’s largest pharma event, which will be hosted at the Frankfurt Messe (1-3 November, 2022) – releases the final part of its annual report with far reaching predictions for 2022 and beyond into 2025 for the nutraceuticals market. The findings explore the long-term trends underway in the global nutraceutical industry, with consumers predicted to increase spending on natural products and sustainable formulations that can offer ‘preventative or proactive’ health b
pharmaphorum
JANUARY 13, 2022
In 2020, over half of total spending on brand medicines went to the supply chain, middlemen and other stakeholders, overtaking the amount going to drug manufacturers for the first time, according to a new study. The report from Berkeley Research Group (BRG) – which was funded by the pharma industry trade group PhRMA – reveals a steady decrease in the proportion received by drugmakers from around 67% in 2013 to 49.5% in 2020.
Outsourcing Pharma
JANUARY 12, 2022
The pharma firm and collaborator Molecular Partners reported positive data out of their Phase II study for ensovibep, an antiviral for treating the virus.
Fierce Healthcare
JANUARY 13, 2022
Express Scripts, Columbia study finds pharmacists taking greater role in patient care. pminemyer. Thu, 01/13/2022 - 13:06.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Pharmig
JANUARY 14, 2022
Unless you’ve been living under a rock for the last few years, you can’t help but have noticed the word sustainability seeping into every single industry. The post Sustainability in the microbiology lab appeared first on Pharmig.
pharmaphorum
JANUARY 10, 2022
The arrival of COVID-19 brought precious few positives, but one that emerged for the pharmaceutical industry was the emergence and validation of mRNA vaccine technology to prevent disease. Ben Hargreaves takes a look at how the space is currently progressing and in what direction it could be heading in future. The pandemic brought about an interesting phenomenon for the pharmaceutical industry: there is a much greater awareness of both individual companies within the industry and their individua
Outsourcing Pharma
JANUARY 13, 2022
Performance Cell Manufacturing, a CDMO with a focus on manufacturing cell therapies, has been acquired by Great Point Partners and will now operate under the name Cellipont Bioservices.
Fierce Healthcare
JANUARY 10, 2022
JPM 2022: Aledade scoops up advance care planning startup Iris Healthcare to build out health services unit. hlandi. Mon, 01/10/2022 - 20:53.
Pharma Tutor
JANUARY 13, 2022
Inauguration of Pharmacy Council of India: First step in Implementation of Pharmacy Act, 1948. About Authors. Dr. R. S. Thakur. Chief Editor, Journal of Pharmaceutical Research. Krupanidhi College of Pharmacy, Bengaluru-560035. Email: drramsthakur@gmail.com. admin. Thu, 01/13/2022 - 17:31. Tags. Articles.
pharmaphorum
JANUARY 12, 2022
The development of gene therapies for Duchenne muscular dystrophy has proved to be challenging, but one of the key players – Sarepta – thinks it may have the clinical data needed to file for regulator approval. The new data from the mid-stage Study 102 of SRP-9001 (delandistrogene moxeparvovec) comes from 21 patients who were initially in the placebo group of the study but crossed over to receive the gene therapy later.
Outsourcing Pharma
JANUARY 14, 2022
According to the companyâs 12th Annual Pharmaceutical Innovation Report, pharmaceutical R&D return on investment has climbed to its highest peak since 2014.
Fierce Healthcare
JANUARY 12, 2022
Lawmakers press OSHA for permanent COVID-19 standard and to reinstall protections. rking. Wed, 01/12/2022 - 11:28.
Druggist
JANUARY 12, 2022
Product Image (name: product-image)Product Image (name: product-image)Product Image (name: product-image)Product Image (name: product-image)Product Image (name: product-image)Product Image (name: product-image)Product Image (name: product-image)Product Image (name: product-image). The post Product Image (name: product-image) appeared first on Druggist.Online.
pharmaphorum
JANUARY 12, 2022
Prospects for Aldeyra’s dry eye disease candidate reproxalap were hit last month after the drug failed to hit its primary objective in a phase 3 trial, but the company isn’t giving up and has new data showing an improvement over Novartis rival therapy Xiidra. Patients treated with reproxalap reported significantly less eye discomfort and itching than those using Xiidra (lifitegrast) in the new phase 2 trial, which Aldeyra said backs up early tolerability comparisons between the drugs
Outsourcing Pharma
JANUARY 13, 2022
A leader from the company discusses challenges in control labs and shares how a new solution aims to clear some key obstacles to greater effectiveness.
Fierce Healthcare
JANUARY 14, 2022
Healthcare conferences to put on your calendar for 2022. hlandi. Fri, 01/14/2022 - 13:08.
Board Vitals - Pharmacist
JANUARY 11, 2022
It’s time to start mentally preparing for the Psychiatric-Mental Health Nurse Practitioner Board Certification Exam. You may be feeling overwhelmed or nervous, but it’s important to set up a study plan so you are prepared for the weeks ahead. Testing yourself with practice questions is also a great way to get in the right mindset. It helps you get an idea of what to expect when taking the real Psychiatric-Mental Health NP exam and identify topics you need to work on.
pharmaphorum
JANUARY 11, 2022
As the COVID-19 pandemic continues to impact the healthcare landscape, and the digital transformation of the life sciences industry gathers pace, what can we expect to see in 2022? In this webinar, senior members from Healthware Group discuss the key trends and developments set to shape the industry and present their predictions for the year ahead. Join us on Friday 21 January at 2.00pm CET to find out how life science companies can stay ahead of the competition in 2022.
Outsourcing Pharma
JANUARY 13, 2022
Two experts from the CRO discuss artificial intelligence, machine language processing, and other analytical tools that can be useful in data management.
Expert insights. Personalized for you.
145 
Let's personalize your content